Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Sep 11;3(3):899-913.
doi: 10.3390/cells3030899.

Roles of Calcium Regulating MicroRNAs in Cardiac Ischemia-Reperfusion Injury

Affiliations
Review

Roles of Calcium Regulating MicroRNAs in Cardiac Ischemia-Reperfusion Injury

Eunhyun Choi et al. Cells. .

Abstract

Cardiac Ca2+ cycling and signaling are closely associated with cardiac function. Changes in cellular Ca2+ homeostasis may lead to aberrant cardiac rhythm and may play a critical role in the pathogenesis of cardiac diseases, due to their exacerbation of heart failure. MicroRNAs (miRNAs) play a key role in the regulation of gene expression at the post-transcriptional level and participate in regulating diverse biological processes. The emerging evidence indicates that the expression profiles of miRNAs vary among human diseases, including cardiovascular diseases. Cardiac Ca2+-handling and signaling proteins are also regulated by miRNAs. Given the relationship between cardiac Ca2+ homeostasis and signaling and miRNA, Ca2+-related miRNAs may serve as therapeutic targets during the treatment of heart failure. In this review, we summarize the knowledge currently available regarding the role of Ca2+ in cardiac function, as well as changes in Ca2+ cycling and homeostasis and the handling of these processes by miRNAs during cardiac ischemia-reperfusion injury.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cardiac Ca2+-handling and Ca2+-mediated signaling. LTCC, L-type Ca2+ channel; NCX, Na+/Ca2+ exchanger; CaM, calmodulin; CaMKII, Ca2+/calmodulin-dependent protein kinase II; Cn, calcineurin; RyR2, ryanodine receptor type-2; SERCA2a, sarcoplasmic reticulum Ca2+-ATPase; SR, sarcoplasmic reticulum; PLB, phospholamban; CICR, Ca2+-induced Ca2+ release; MCU, mitochondrial Ca2+ uniporter; ANT, adenine nucleotide transporter; VDAC, voltage-dependent anion channel; TCA, tricarboxylic acid; OXPHOS, oxidative phosphorylation; HDAC, histone deacetylase; NFAT, nuclear factor of activated T-cells; MEF2, myocyte enhancer factor-2; P, phosphorylation.
Figure 2
Figure 2
Cardiac Ca2+ protein-regulated microRNA during ischemia-reperfusion injury. LTCC, L-type Ca2+ channel; NCX, Na+/Ca2+ exchanger; AnxA5, annexin A5; NHE, Na+/H+ exchanger; CaM, calmodulin; CaMKII, Ca2+/calmodulin-dependent protein kinase II; RyR2, ryanodine receptor type-2; SERCA2a, sarcoplasmic reticulum Ca2+-ATPase; SR, sarcoplasmic reticulum; PLB, phospholamban; CICR, Ca2+-induced Ca2+ release; MCU, mitochondrial Ca2+ uniporter; ROS, reactive oxygen species; CyP-D, cyclophilin D; mPTP, mitochondrial permeability transition pore; OXPHOS, oxidative phosphorylation; HDAC, histone deacetylase; P, phosphorylation.

Similar articles

Cited by

References

    1. Luo M., Anderson M.E. Mechanisms of altered Ca2+ handling in heart failure. Circ. Res. 2013;113:690–708. doi: 10.1161/CIRCRESAHA.113.301651. - DOI - PMC - PubMed
    1. Buja L.M. Myocardial ischemia and reperfusion injury. Cardiovasc. Pathol. 2005;14:170–175. doi: 10.1016/j.carpath.2005.03.006. - DOI - PubMed
    1. Viola H.M., Hool L.C. How does calcium regulate mitochondrial energetics in the heart?—New insights. Heart Lung Circ. 2014;23:602–609. doi: 10.1016/j.hlc.2014.02.009. - DOI - PubMed
    1. Kho C., Lee A., Hajjar R.J. Altered sarcoplasmic reticulum calcium cycling—targets for heart failure therapy. Nat. Rev. Cardiol. 2012;9:717–733. doi: 10.1038/nrcardio.2012.145. - DOI - PMC - PubMed
    1. Peterson S.M., Thompson J.A., Ufkin M.L., Sathyanarayana P., Liaw L., Congdon C.B. Common features of microRNA target prediction tools. Front. Genet. 2014;5:23. doi: 10.3389/fgene.2014.00023. - DOI - PMC - PubMed